PineBridge Investments’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-2,348
| Closed | -$129K | – | 1050 |
|
|
2019
Q3 | $129K | Buy |
2,348
+895
| +62% | +$49.2K | ﹤0.01% | 907 |
|
|
2019
Q2 | $59K | Sell |
1,453
-22,149
| -94% | -$899K | ﹤0.01% | 882 |
|
|
2019
Q1 | $714K | Buy |
+23,602
| New | +$714K | 0.01% | 617 |
|
|
2018
Q2 | – | Sell |
-4,267
| Closed | -$212K | – | 1079 |
|
|
2018
Q1 | $212K | Sell |
4,267
-5,744
| -57% | -$285K | 0.01% | 882 |
|
|
2017
Q4 | $539K | Buy |
10,011
+8,192
| +450% | +$441K | 0.01% | 801 |
|
|
2017
Q3 | $105K | Sell |
1,819
-112
| -6% | -$6.47K | ﹤0.01% | 934 |
|
|
2017
Q2 | $95K | Buy |
1,931
+21
| +1% | +$1.03K | ﹤0.01% | 929 |
|
|
2017
Q1 | $83K | Buy |
1,910
+31
| +2% | +$1.35K | ﹤0.01% | 960 |
|
|
2016
Q4 | $92K | Hold |
1,879
| – | – | ﹤0.01% | 995 |
|
|
2016
Q3 | $90K | Buy |
1,879
+61
| +3% | +$2.92K | ﹤0.01% | 817 |
|
|
2016
Q2 | $98K | Buy |
1,818
+98
| +6% | +$5.28K | 0.01% | 768 |
|
|
2016
Q1 | $77K | Sell |
1,720
-244
| -12% | -$10.9K | ﹤0.01% | 801 |
|
|
2015
Q4 | $75K | Buy |
1,964
+74
| +4% | +$2.83K | ﹤0.01% | 848 |
|
|
2015
Q3 | $61K | Buy |
1,890
+181
| +11% | +$5.84K | ﹤0.01% | 889 |
|
|
2015
Q2 | $56K | Sell |
1,709
-2,188
| -56% | -$71.7K | ﹤0.01% | 920 |
|
|
2015
Q1 | $161K | Buy |
3,897
+618
| +19% | +$25.5K | 0.01% | 805 |
|
|
2014
Q4 | $133K | Buy |
3,279
+139
| +4% | +$5.64K | 0.01% | 844 |
|
|
2014
Q3 | $115K | Buy |
3,140
+1,279
| +69% | +$46.8K | ﹤0.01% | 819 |
|
|
2014
Q2 | $86K | Sell |
1,861
-895
| -32% | -$41.4K | ﹤0.01% | 836 |
|
|
2014
Q1 | $114K | Sell |
2,756
-276
| -9% | -$11.4K | ﹤0.01% | 915 |
|
|
2013
Q4 | $116K | Buy |
+3,032
| New | +$116K | ﹤0.01% | 928 |
|